Epidemiology of human T-lymphotropic virus type 1 among blood donors and general population in Iran: a meta-analysis

References

• 1 Mahieux R, Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol. Biol. 57(2), 161–166 (2009).
  Medline CASGoogle Scholar
• 2 Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3, 388 (2012).
  MedlineGoogle Scholar
• 3 Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452), 407–410 (1985).
  Medline CASGoogle Scholar
• 4 Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl Acad. Sci. USA 78(10), 6476–6480 (1981).
  Medline CASGoogle Scholar
• 5 Saito M, Jain P, Tsukasaki K, Bangham CR. HTLV-1 infection and its associated diseases. Leuk. Res. Treat. 2012, 123637 (2012).
  MedlineGoogle Scholar
• 6 Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC et al. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24(39), 6058–6068 (2005).
  Medline CASGoogle Scholar
• 7 Farid R, Shirdel A, Tabei SZ. Clinical manifestation of adult T cell lymphoma/leukemia associated with HTLV-1 in north-eastern Iran. Iran. J. Med. Sci. 17, 105–108 (1992).
  Google Scholar
• 8 Farid Hosseini R, Parizadeh MJ, Ghafari J, Miri S, Nasirian A, Rafat Panah H. Seroepidemiology of HTLV-1 infection in Neishabour. Med. J. Mashhad Univ. Med. Sci. 47(4), 417–424 (2005).
  Google Scholar
• 9 Meytes D, Schochat B, Lee H et al. Serological and molecular survey for HTLV-1 infection in a high-risk Middle Eastern group. Lancet 336(8730), 1533–1535 (1990).
  Medline CASGoogle Scholar
• 10 Rafatpanah R, Hedayati-Moghaddam MR, Fathimoghadam F et al. High prevalence of HTLV-1 infection in Mashhad, northeast Iran: a population-based seroepidemiology survey. J. Clin. Virol. 52(3), 172–176 (2011).
  MedlineGoogle Scholar
• 11 Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I et al. Epidemiology of HTLV-1 in Neyshabour, northeast of Iran. Iran Red. Crescent Med. J. 13(6), 424–427 (2011).
  Medline CASGoogle Scholar
• 12 Rafatpanah H, Torkamani M, Valizadeh N et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J. Med. Virol. 88(7), 1247–1253 (2016).
  Medline CASGoogle Scholar
• 13 Azarpazhooh M, Hasanpoor K, Ghanbari M et al. HTLV-1 prevalence in northeastern Iran, Sabzevar: an epidemiologic based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 28(9), 1095–1101 (2012).
  MedlineGoogle Scholar
• 14 Safai B, Huang JL, Boeri E et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res. Hum. Retroviruses 10, 1185–1190 (1996).
  Google Scholar
• 15 Rezvan H, Ahmadi J, Farhadi M. A cluster of HTLV-1 infection in northeastern of Iran. Transfus. Today. 7, 8–9 (1996).
  Google Scholar
• 16 Abbaszadegan MR, Gholamin M, Tabatabaee A et al. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J. Clin. Microbiol. 41(6), 2593–2595 (2003).
  MedlineGoogle Scholar
• 17 Ghafouri M, Ameli MR. Transfusion transmitted viral infections in blood donors of south Khorasan. Sci. J. Iran Blood Transfus. Organ. 7(4), 242–248 (2011).
  Google Scholar
• 18 Tavanai Sani A. Serologic prevalence of HTLV among blood donors in Mashhad (northeastern Iran). Arch. Iran. Med. 4(1), 25–26 (2011).
  Google Scholar
• 19 Tarhini M, Kchour G, Sayadpour Zanjani D et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology 41(5), 498–9 (2009).
  MedlineGoogle Scholar
• 20 Haghighi S, Jalalian M, Bazargani R et al. Co-infection between HTLV-1,2 and other transfusion transmissible viral infections in Mashhadi blood donors. Proceedings of the 1st International Congress on HTLV-1 and Associated Siseases in Iran. Mashhad, Iran, 18–20 February, 2010.
  Google Scholar
• 21 Shahabi M, Sayadpour Zanjani D, Tehranian F. Seroindeterminate HTLV-1/II prevalence and characteristics in blood donors of Northeast of Iran. Proceedings of the 1st International Congress on HTLV-1 and Associated Diseases in Iran. Mashhad, Iran, 18–20 February, 2010.
  Google Scholar
• 22 Sayadpour Zanjani D, Shahabi M, Talaei N, Afzalaghaee M, Tehranian F, Bazargani R. Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from northeast Iran: evidence of proviral tax, env, and gag sequences. AIDS Res Hum Retroviruses. 26(12), 1–5 (2010).
  MedlineGoogle Scholar
• 23 Rakhshan Masoudi Z, Yazdanparast E, Omidkhoda A, Zarei N, Firoozbakhat S, Zarei M. Frequency of human T-lymphotropic virus type 1,2 among blood donors from Karaj transfusion centre. Proceedings of the 1st International Congress on HTLV-1 and Associated Diseases in Iran. Mashhad, Iran, 18–20 February, 2010. P-30.
  Google Scholar
• 24 Rostamzadeh Khameneh Z, Baradaran M et al. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J. Kidney Dis. Transpl. 19(5), 838–841 (2008).
  MedlineGoogle Scholar
• 25 Falahi S, Sabahi F, Zeynali M et al. Incidince of human T-lymphotropic virus type 1 (HTLV-1) among blood donors from Ilam, Iran. Iran. J. Virol. 1(3), 11–14 (2008).
  Google Scholar
• 26 PourKarim MR, KhamisiPour Gh R, Zandi K et al. Prevalence of anti-HTLV-1 & anti- HTLV-1I antibodies in blood donors in Bushehr province. Iran. South Med. J. 6(2), 161–164 (2004).
  Google Scholar
• 27 Abedi F, Yavaian M, Shakibzadeh A et al. A pilot seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan. Med. J. Hormozgan Univ. 13(2), 75–80 (2009).
  Google Scholar
• 28 Marvi MS, Jamili P, Safabakhsh HR et al. Survey of frequency and Geographical distribution Of HTLV infection among blood donors in Neyshabour blood bank, 2003–2009. Proceedings of the 7th Annual Research Conference of Eastern Medical Sciences Students. (2011), Mashhad, Iran. Abstract A–10–851–1.
  Google Scholar
• 29 Karimi A, Nafici MR, Imani R. Comparison of human T-cell Leukemia virus type-I (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari province, iran. Kuwait Med. J. 39(3), 259–261 (2007).
  Google Scholar
• 30 Karimi G, Zadsar M, Pourfathollah AA. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virol J. 14(1), 14 (2017).
  MedlineGoogle Scholar
• 31 Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Glob. J. Health Sci. 6(5), 99–104 (2014).
  MedlineGoogle Scholar
• 32 Hatami H, Karimi G, Safabakhsh H. Seroepidemiologic prevalence of HTLV in voluntary blood donors in Mashhad. Sci. J. Iran. Blood Transfus. Organ. 9(2), 149–159 (2012).
  Google Scholar
• 33 Jamili P, Safabakhsh MS, Marvi H et al. Seroepidemiology of HTLV infection in Sabzevar blood donors from 2007 to 2008. J. Sabzevar Univ. Med. Sci. 20(4), 464–471 (2014).
  Google Scholar
• 34 Safabakhsh HR, Karimi G, Hatami H. The prevalence of HTLV -1 infection in blood donation volunteers in Mashhad. J. Sch. Public Health Inst. Public Health Res. 11(4), 85–94 (2014).
  Google Scholar
• 35 Maghsudlu M, Safabakhsh H, Jamili P. Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar. Asian J. Transfus. Sci. 9(2), 203 (2015).
  Medline CASGoogle Scholar
• 36 Sayehmiri K, Tavan H, Sayehmiri F et al. Prevalence of epilepsy in Iran: a meta-analysis and systematic review. Iran. J. Child. Neurol. 8(4), 9-17 (2014).
  MedlineGoogle Scholar
• 37 Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62(10), 1006–1012 (2009).
  MedlineGoogle Scholar
• 38 Tavan H, Sayehmiri K et al. Prevalence of peptic ulcer in Iran using the meta-analysis and systematic review. GOVARESH 20, 250–258 (2016).
  Google Scholar
• 39 Sayehmiri K, Abangah G, Kalvandi G et al. Prevalence of peptic ulcer in Iran: systematic review and meta-analysis methods. J Res Med Sci. 23(1), 8– (2014).
  Google Scholar
• 40 Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses (2011). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  Google Scholar
• 41 Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med. Decis. Making. 25(6), 646–654 (2005).
  Medline CASGoogle Scholar
• 42 Borenstein M, Hedges LV, Higgins JPT et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods 1(2), 97–111 (2010).
  MedlineGoogle Scholar
• 43 Azami M, Khataee M, Bigam Bigdeli-Shamlo M et al. Prevalence and risk factors of hepatitis B infection in pregnant women of Iran: a systematic review and meta-analysis. IJOG. 19(18), 17–30 (2016).
  Google Scholar
• 44 Gessain A. Epidemiology of HTLV-1 and associated diseases. In: Hollsberg P, Hafler DA (Eds). Human T cell Lymphotropic Virus Type I. Wiley and Sons, NY, USA, 33–50 (1996).
  Google Scholar
• 45 Macía C, Vargas S, Mora AM et al. Seroprevalence of human T-lymphotropic virus in blood bank donors at Fundación Valle del Lili, Cali, Colombia, 2008–2014. Biomédica 36, 108–115 (2016).
  MedlineGoogle Scholar
• 46 Niazi SK, Bhatti FA, Salamat N. Seroprevalence of human T-cell lymphotropic virus-1/2 in blood donors in northern Pakistan: implications for blood donor screening. J Coll Physicians Surg Pak. 25(12), 874–877 (2015).
  MedlineGoogle Scholar
• 47 Li X, Chen Y, Wu Z et al. Prevalence of human T-lymphotropic virus type 1 infection among blood donors in mainland China: a meta-analysis. Int. J. Infect. Dis. 25, 94–9 (2014).
  MedlineGoogle Scholar
• 48 Chang YB, Kaidarova Z, Hindes D et al. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors – United States, 2000–2009. J Infect Dis. 209(4), 523–531 (2014).
  Medline CASGoogle Scholar
• 49 Dayyani M, Hedayati-Moghaddam MR, Amini AR. HTLV-1 infection as a serious health issue among Iranian multi-transfused patients: evidence from a systematic review and meta-analysis. Iran J Blood Cancer. 7(2), 85–94 (2015).
  Google Scholar
• 50 Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC et al. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24(39), 6058–6068 (2005).
  Medline CASGoogle Scholar
• 51 Matsuoka M, Jeang KT. Human T-cell leukemia virus type I at age 25: a progress report. Cancer Res. 65(11), 4467–4470 (2005).
  Medline CASGoogle Scholar
• 52 Verdonck K, González E, Van Dooren S et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 7(4), 266–281 (2007).
  Medline CASGoogle Scholar
• 53 Abolghasemi H, Maghsudlu M, Amini Kafi-Abad S et al. Introduction to iranian blood transfusion organization and blood safety in Iran. Iran. J. Public Health. 38(Suppl. 1), 82–87 (2009).
  Google Scholar
• 54 Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus. Med. 17(6), 425–433 (2007).
  Medline CASGoogle Scholar